Loading clinical trials...
Loading clinical trials...
The study described here is being conducted to prospectively confirm the performance of the ExoDx Prostate gene expression assay in patients presenting for an initial prostate biopsy and support of CE...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Exosome Diagnostics, Inc.
NCT07416630 · Gynecologic Cancer, Urologic Cancer, and more
NCT06398314 · Gastrointestinal Cancer, Urologic Cancer, and more
NCT06537037 · Urologic Cancer
NCT06111235 · Non Muscle Invasive Bladder Cancer, Urologic Cancer, and more
NCT05725304 · Urologic Cancer
Chesapeake Urology Research Associates
Baltimore, Maryland
New Jersey Urology
Voorhees Township, New Jersey
Klinikum der Universität München
München
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions